Key result
Novel Nav1.9 N816K mutation reduces action potential threshold ~44%, rendering DRG neurons hyperexcitable.
Why the study?
Gain-of-function variants in Nav1.9 have been identified in patients with familial episodic pain and small fiber neuropathy, but the phenotypic spectrum of Nav1.9 channelopathy remains to be explored.
Case Report (n=1)
The novel Nav1.9-N816K mutation exhibits gain-of-function attributes at the channel and cellular levels, consistent with the episodic pain phenotype observed in the patient.
May link Nav1.9 gain-of-function to human pain; leaves open clinical translation from animal DRG models.
Voltage-gated sodium channel Nav1.9 is a threshold channel that regulates action potential firing. Nav1.9 is preferentially expressed in myenteric neurons, and small-diameter dorsal root ganglion (DRG) and trigeminal ganglion neurons including nociceptors. Recent studies have demonstrated a monogenic Mendelian link of Nav1.9 to human pain disorders. Gain-of-function variants in Nav1.9, which cause smaller depolarizations of RMP, have been identified in patients with familial episodic pain type 3 (FEPS3) and the more common pain disorder small fiber neuropathy. To explore the phenotypic spectrum of Nav1.9 channelopathy, here we report a new Nav1.9 mutation, N816K, in a child with early-onset episodic pain in both legs, episodic abdominal pain, and chronic constipation. Sequencing of further selected pain genes was normal. N816K alters a residue at the N-terminus of loop 2, proximal to the cytoplasmic terminus of transmembrane segment 6 in domain II. Voltage-clamp recordings demonstrate that Nav1.9-N816K significantly increases current density and hyperpolarizes voltage-dependence of activation by 10 mV, enabling a larger window current. Current-clamp recordings in DRG neurons shows that N816K channels depolarize RMP of small DRG neurons by 7 mV, reduce current threshold of firing an action potential and render DRG neurons hyperexcitable. Taken together these data demonstrate gain-of-function attributes of the newly described N816K mutation at the channel and cellular levels, which are consistent with a pain phenotype in the carrier of this mutation.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2019) conducted a case report in Familial episodic pain type 3 (FEPS3) (n=1). Nav1.9 N816K mutation vs. Wild-type Nav1.9 was evaluated on Electrophysiological properties of Nav1.9 channels and DRG neuronal excitability. The novel Nav1.9 N816K mutation hyperpolarizes the voltage-dependence of activation by 10 mV and reduces the current threshold for action potentials by 44%, rendering DRG neurons hyperexcitable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: